{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T18:07:06Z","timestamp":1771610826785,"version":"3.50.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,20]]},"DOI":"10.7759\/cureus.103982","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T17:15:59Z","timestamp":1771607759000},"source":"Crossref","is-referenced-by-count":0,"title":["Monitoring the Response of a Pineal Parenchymal Tumor of Intermediate Differentiation With Cerebrospinal Fluid Dissemination Using a Circulating Tumor Cell Assay"],"prefix":"10.7759","author":[{"given":"Matthew","family":"Pelletier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"BK","family":"Kleinschmidt-Demasters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Perry","family":"Corkos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony J","family":"Pircher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise","family":"Damek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santosh","family":"Kesari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noac202","article-title":"CBTRUS Statistical Report: primary brain and other central nervous system tumors diagnosed in the United States in 2015-2019","volume":"24","author":"Ostrom QT","year":"2022","unstructured":"Ostrom QT, Price M, Neff C, Cioffi G, Waite KA, Kruchko C, Barnholtz-Sloan JS. CBTRUS Statistical Report: primary brain and other central nervous system tumors diagnosed in the United States in 2015-2019. Neuro Oncol. 2022, 24:v1-v95. 10.1093\/neuonc\/noac202","journal-title":"Neuro Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis DN","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, et al.. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 2021, 23:1231-51. 10.1093\/neuonc\/noab106","journal-title":"Neuro Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2016.10.025","article-title":"Patterns of care and survival outcomes in patients with pineal parenchymal tumor of intermediate differentiation: an individual patient data analysis","volume":"121","author":"Mallick S","year":"2016","unstructured":"Mallick S, Benson R, Rath GK. Patterns of care and survival outcomes in patients with pineal parenchymal tumor of intermediate differentiation: an individual patient data analysis. Radiother Oncol. 2016, 121:204-8. 10.1016\/j.radonc.2016.10.025","journal-title":"Radiother Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-021-03863-y","article-title":"Prognosticating survival of pineal parenchymal tumors of intermediate differentiation (PPTID) by grade","volume":"155","author":"Lu VM","year":"2021","unstructured":"Lu VM, Luther EM, Eichberg DG, Morell AA, Shah AH, Komotar RJ, Ivan ME. Prognosticating survival of pineal parenchymal tumors of intermediate differentiation (PPTID) by grade. J Neurooncol. 2021, 155:165-72. 10.1007\/s11060-021-03863-y","journal-title":"J Neurooncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-023-04310-w","article-title":"Clinicopathologic analysis of pineal parenchymal tumors of intermediate differentiation: a multi-institutional cohort study by the Kyushu Neuro-Oncology Study Group","volume":"162","author":"Yamashita S","year":"2023","unstructured":"Yamashita S, Takeshima H, Hata N, et al.. Clinicopathologic analysis of pineal parenchymal tumors of intermediate differentiation: a multi-institutional cohort study by the Kyushu Neuro-Oncology Study Group. J Neurooncol. 2023, 162:425-33. 10.1007\/s11060-023-04310-w","journal-title":"J Neurooncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2023.101624","article-title":"Leptomeningeal metastasis from solid tumours: EANO-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"8","author":"Le Rhun E","year":"2023","unstructured":"Le Rhun E, Weller M, van den Bent M, et al.. Leptomeningeal metastasis from solid tumours: EANO-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. ESMO Open. 2023, 8:101624. 10.1016\/j.esmoop.2023.101624","journal-title":"ESMO Open"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noae171","article-title":"NANO-LM: an updated scorecard for the clinical assessment of patients with leptomeningeal metastases","volume":"27","author":"Le Rhun E","year":"2025","unstructured":"Le Rhun E, Nayak L, Lim-Fat MJ, et al.. NANO-LM: an updated scorecard for the clinical assessment of patients with leptomeningeal metastases. Neuro Oncol. 2025, 27:455-65. 10.1093\/neuonc\/noae171","journal-title":"Neuro Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noz024","article-title":"The RANO Leptomeningeal Metastasis Group proposal to assess response to treatment: lack of feasibility and clinical utility and a revised proposal","volume":"21","author":"Le Rhun E","year":"2019","unstructured":"Le Rhun E, Devos P, Boulanger T, et al.. The RANO Leptomeningeal Metastasis Group proposal to assess response to treatment: lack of feasibility and clinical utility and a revised proposal. Neuro Oncol. 2019, 21:648-58. 10.1093\/neuonc\/noz024","journal-title":"Neuro Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.clbc.2021.11.002","article-title":"Diagnosis of leptomeningeal metastasis in women with breast cancer through identification of tumor cells in cerebrospinal fluid using the cnside\u2122 assay","volume":"22","author":"Wooster M","year":"2022","unstructured":"Wooster M, McGuinness JE, Fenn KM, et al.. Diagnosis of leptomeningeal metastasis in women with breast cancer through identification of tumor cells in cerebrospinal fluid using the cnside\u2122 assay. Clin Breast Cancer. 2022, 22:e457-62. 10.1016\/j.clbc.2021.11.002","journal-title":"Clin Breast Cancer"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-023-01432-2","article-title":"Diagnostic and therapeutic updates in leptomeningeal disease","volume":"25","author":"Roy-O'Reilly MA","year":"2023","unstructured":"Roy-O'Reilly MA, Lanman T, Ruiz A, Rogawski D, Stocksdale B, Nagpal S. Diagnostic and therapeutic updates in leptomeningeal disease. Curr Oncol Rep. 2023, 25:937-50. 10.1007\/s11912-023-01432-2","journal-title":"Curr Oncol Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-11-0215","article-title":"A novel platform for detection of CK+ and CK- CTCs","volume":"1","author":"Pecot CV","year":"2011","unstructured":"Pecot CV, Bischoff FZ, Mayer JA, et al.. A novel platform for detection of CK+ and CK- CTCs. Cancer Discov. 2011, 1:580-6. 10.1158\/2159-8290.CD-11-0215","journal-title":"Cancer Discov"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/412607-monitoring-the-response-of-a-pineal-parenchymal-tumor-of-intermediate-differentiation-with-cerebrospinal-fluid-dissemination-using-a-circulating-tumor-cell-assay","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T17:15:59Z","timestamp":1771607759000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/412607-monitoring-the-response-of-a-pineal-parenchymal-tumor-of-intermediate-differentiation-with-cerebrospinal-fluid-dissemination-using-a-circulating-tumor-cell-assay"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.103982","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,20]]}}}